PO-0928: Safety and efficacy of concomitant RT and CDK4/6 inhibitors in metastatic breast cancer patients. (November 2020) - Visani, L.; Saieva, C.; Desideri, I.; Scotti, V.; Dominici, L.; Scoccimarro, E.; Aquilano, M.; Cerbai, C.; Palmieri, V.E.; Maragna, V.; Becherini, C.; Bernini, M.; et al.